Besse B, Subbiah V, Curigliano G, Bowles DW, et al. Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer. J Clin Oncol 2026 Mar 26:JCO2501489. doi: 10.1200/JCO-25-01489.
PMID: 41886723